145 related articles for article (PubMed ID: 37986603)
21. Pharmacological treatment of hypercortisolism.
Shalet S; Mukherjee A
Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):234-8. PubMed ID: 18438170
[TBL] [Abstract][Full Text] [Related]
22. [Diagnosis and therapy of endogenic hypercortisolism (Cushing's syndrome)].
Meng W; Meng S
Z Arztl Fortbild (Jena); 1972 Oct; 66(20):1025-31. PubMed ID: 4346727
[No Abstract] [Full Text] [Related]
23. Posterior subcapsular cataract in endogenous Cushing syndrome: an uncommon manifestation.
Bouzas EA; Mastorakos G; Friedman TC; Scott MH; Chrousos GP; Kaiser-Kupfer MI
Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3497-500. PubMed ID: 8258505
[TBL] [Abstract][Full Text] [Related]
24. The use of mifepristone in the treatment of Cushing's syndrome.
Carroll T; Findling JW
Drugs Today (Barc); 2012 Aug; 48(8):509-18. PubMed ID: 22916338
[TBL] [Abstract][Full Text] [Related]
25. Pneumocystis pneumonia can complicate medical treatment of hypercortisolism even in outpatients with Cushing's disease.
Cristante J; Lepelley M; Mallaret M; Carreau A; Chabre O
Ann Endocrinol (Paris); 2020 Dec; 81(6):551-560. PubMed ID: 33278378
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Control of Hypercortisolism by Vandetanib in a Case of Medullary Thyroid Carcinoma with a Somatic RET Mutation.
Paepegaey AC; Cochand-Priollet B; Louiset E; Sarfati PO; Alifano M; Burnichon N; Bienvenu-Perrard M; Lahlou N; Bricaire L; Groussin L
Thyroid; 2017 Apr; 27(4):587-590. PubMed ID: 28068878
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Cushing's disease. Correction of hypercortisolism by o,p'DDD without induction of aldosterone deficiency.
Temple TE; Jones DJ; Liddle GW; Dexter RN
N Engl J Med; 1969 Oct; 281(15):801-5. PubMed ID: 4309238
[No Abstract] [Full Text] [Related]
28. Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome.
Prete A; Paragliola RM; Bottiglieri F; Rota CA; Pontecorvi A; Salvatori R; Corsello SM
Endocrine; 2017 Mar; 55(3):969-980. PubMed ID: 27395418
[TBL] [Abstract][Full Text] [Related]
29. Preventive action of Panax ginseng roots in hypercortisolism-induced Impairment of hippocampal neurons in male C57BL/6N mice.
Wang Z; Dai J; Chen L; Huang Y; Zhao Y
Phytother Res; 2011 Aug; 25(8):1242-5. PubMed ID: 21796698
[TBL] [Abstract][Full Text] [Related]
30. Unexpected adverse effect of metyrapone: A case report.
Rouland A; Nguyen A; Fourmont C; Lapray M; Vergès B; Petit JM; Bouillet B
Clin Endocrinol (Oxf); 2018 Jul; 89(1):112-113. PubMed ID: 29672894
[No Abstract] [Full Text] [Related]
31. Longitudinal Monitoring of Hair Cortisol Using Liquid Chromatography-Mass Spectrometry to Prevent Hypercortisolism in Patients Undergoing Glucocorticoid Replacement Therapy: Erratum.
Ther Drug Monit; 2022 Aug; 44(4):597. PubMed ID: 35821592
[No Abstract] [Full Text] [Related]
32. [Indications and future perspectives in the pharmacological treatment of hypercortisolism].
Stigliano A; Toscano V
Recenti Prog Med; 2016 Mar; 107(3):143-8. PubMed ID: 27030224
[TBL] [Abstract][Full Text] [Related]
33. Pneumocystis pneumonia during medicamentous treatment of Cushing's syndrome--a description of two cases.
Gabalec F; Zavrelová A; Havel E; Cerman J; Radocha J; Svilias I; Cáp J
Acta Medica (Hradec Kralove); 2011; 54(3):127-30. PubMed ID: 22250484
[TBL] [Abstract][Full Text] [Related]
34. Role of "old" pharmacological agents in the treatment of Cushing's syndrome.
Ambrogio AG; Cavagnini F
J Endocrinol Invest; 2016 Sep; 39(9):957-65. PubMed ID: 27086313
[TBL] [Abstract][Full Text] [Related]
35. Cushing syndrome in a young woman due to primary pigmented nodular adrenal disease.
Hackman KL; Davis AL; Curnow PA; Serpell JW; McLean CA; Topliss DJ
Endocr Pract; 2010; 16(1):84-8. PubMed ID: 19703806
[TBL] [Abstract][Full Text] [Related]
36. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone.
Close CF; Mann MC; Watts JF; Taylor KG
Clin Endocrinol (Oxf); 1993 Sep; 39(3):375-9. PubMed ID: 8222300
[TBL] [Abstract][Full Text] [Related]
37. Alcohol-induced Cushing syndrome: report of eight cases and review of the literature.
Surani A; Carroll TB; Javorsky BR; Raff H; Findling JW
Front Endocrinol (Lausanne); 2023; 14():1199091. PubMed ID: 37409223
[TBL] [Abstract][Full Text] [Related]
38. Fever of unexplained origin, biochemical Cushing's disease and cerebral dysrhythmia corrected by valproate sodium.
López-Moreno JM; Rodríguez-Portales JA; Mahana D
Can Med Assoc J; 1985 Jan; 132(2):150-4. PubMed ID: 3917350
[TBL] [Abstract][Full Text] [Related]
39. Pregnancy in Patients with Cushing's Syndrome.
Machado MC; Fragoso MCBV; Bronstein MD
Endocrinol Metab Clin North Am; 2018 Jun; 47(2):441-449. PubMed ID: 29754643
[TBL] [Abstract][Full Text] [Related]
40. Adrenal mild hypercortisolism.
Goddard GM; Ravikumar A; Levine AC
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):371-9. PubMed ID: 26038206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
